Monitoring Volatile Organic Compound Profiles in Exhaled Breath to Noninvasively Detect Glycemic Events in Patients With Diabetes
The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.
• Who are diagnosed with type 1 diabetes.
• Who are between 12-19 years of age.
• That utilize a Dexcom (G6 or G7) continuous glucose monitoring device.
• That have an established working CGM for at least 12 hours (that does not need to be replaced within 24 hours).
• That are willing to share their daily CGM data for the study.
• That are the only individuals in their household with any type of diabetes diagnosis (type 1 or type 2).
• That are willing to return the device within 24-48 hours of study completion.
• That are located in Indianapolis, IN or its suburban areas.